Search - tctmd.com

Displaying 581 - 600 of 831

Sort: Relevancy | Date

Presentation TCT 2015

Valve Thrombosis/Leaflet Thickening: To Treat or Not to Treat

Presenter: Nicole Ibrahim, Martin B. Leon, Raj Makkar

October 14, 2015

Presentation TCT 2015

Identifying and Studying Data Gaps: DAPT Duration What's Settled, and What's Not?

Presenter: Deepak L. Bhatt, Martin Rose, John A. Bittl

October 14, 2015

Presentation TCT 2015

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

Presenter: Deepak L. Bhatt, Martin Rose, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

When and How to Treat a Claudicant With an Occluded SFA

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

Presentation TCT 2015

Together Were better. On Engagement, Empowerment, and Autonomy

Presenter: Aaron V. Kaplan, Hugo Campos

October 13, 2015

Presentation TCT 2015

The Conundrum of Cost-effective but Unaffordable Care: The Plight of High-Tech New Interventional Therapies

Presenter: Aaron V. Kaplan, David J. Cohen

October 13, 2015

Presentation TCT 2015

The Evolving CMS Reimbursement Process: How Can CMS Promote Innovation, and What Clinical Data Make a Difference?

Presenter: Aaron V. Kaplan, James Rollins

October 13, 2015

Presentation TCT 2015

Anticipated Changes in the European Regulatory Landscape: Impact on Device Development and Innovation

Presenter: Aaron V. Kaplan, Angeles Alonso Garcia

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 4 Academia Perspectives

Presenter: Roxana Mehran, Laura Mauri

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 3 Industry Perspectives

Presenter: Roxana Mehran, Keith D. Dawkins

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 2 EMA Perspectives

Presenter: Roxana Mehran, Angeles Alonso Garcia

October 13, 2015

Presentation TCT 2015

Big Data: Opportunities and Challenges 1 FDA Perspectives

Presenter: Roxana Mehran, John C Laschinger

October 13, 2015

Presentation TCT 2015

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

Presenter: Roxana Mehran, Robert A. Harrington

October 13, 2015

Presentation TCT 2015

TCT 48: Early Vascular Responses to Everolimus-Eluting Cobalt-Chromium Stent for the Treatment of Stable Coronary Artery Disease The Results of MECHANISM Elective 1-Month OCT Follow-up Cohort

Presenter: Stephan Achenbach, Marc D. Feldman, Toshiro Shinke

October 13, 2015

Presentation TCT 2015

A White Paper From EFS Physician Enthusiasts: Honest Appraisals and Lessons Learned

Presenter: Andrew Farb, Michael J. Mack

October 13, 2015

Presentation TCT 2015

TCT 46: OCT-Based Management of Late-Stent Thrombosis Results From the SAFE Registry

Presenter: Stephan Achenbach, Marc D. Feldman, Catalin Toma

October 13, 2015

Presentation TCT 2015

The Early Feasibility Study (EFS) Program: First-Term Report Card

Presenter: Andrew Farb, Michael J. Mack

October 13, 2015

Presentation TCT 2015

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

Presenter: Gregg W. Stone, Bram D. Zuckerman, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

Advertisement

Valve Thrombosis/Leaflet Thickening: To Treat or Not to Treat

Identifying and Studying Data Gaps: DAPT Duration What's Settled, and What's Not?

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

When and How to Treat a Claudicant With an Occluded SFA

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Together Were better. On Engagement, Empowerment, and Autonomy

The Conundrum of Cost-effective but Unaffordable Care: The Plight of High-Tech New Interventional Therapies

The Evolving CMS Reimbursement Process: How Can CMS Promote Innovation, and What Clinical Data Make a Difference?

Anticipated Changes in the European Regulatory Landscape: Impact on Device Development and Innovation

Big Data: Opportunities and Challenges 4 Academia Perspectives

Big Data: Opportunities and Challenges 3 Industry Perspectives

Big Data: Opportunities and Challenges 2 EMA Perspectives

Big Data: Opportunities and Challenges 1 FDA Perspectives

Is the Answer Pragmatic/Simple Trials? Are They Really So Simple?

TCT 48: Early Vascular Responses to Everolimus-Eluting Cobalt-Chromium Stent for the Treatment of Stable Coronary Artery Disease The Results of MECHANISM Elective 1-Month OCT Follow-up Cohort

A White Paper From EFS Physician Enthusiasts: Honest Appraisals and Lessons Learned

TCT 46: OCT-Based Management of Late-Stent Thrombosis Results From the SAFE Registry

The Early Feasibility Study (EFS) Program: First-Term Report Card

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content